Pulmonary thromboembolism superimposed on a congenital ventricular septal defect in a 50-year-old man inhaled nitric oxide and sildenafil to the rescue
- PMID: 15191635
- DOI: 10.1097/01.crd.0000122635.12743.57
Pulmonary thromboembolism superimposed on a congenital ventricular septal defect in a 50-year-old man inhaled nitric oxide and sildenafil to the rescue
Abstract
We report the combined use of inhaled nitric oxide (iNO) and sildenafil to selectively lower pulmonary vascular resistance (PVR) and reverse right-to-left shunt flow across a congenital ventricular septal defect (VSD) in a 50-year-old man. The patient developed right-to-left shunt flow with profound hypoxia because of an acute pulmonary embolism superimposed on underlying pulmonary hypertension. The dramatic improvement in oxygenation and PVR with sildenafil plus iNO has been sustained with sildenafil monotherapy. To our knowledge, use of this combination therapy in patients with decompensated pulmonary arterial hypertension (PAH) and a predisposition to right-to-left shunting has not been previously reported.
Copyright 2004 Lippincott Williams and Wilkins
Similar articles
-
Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery.Intensive Care Med. 2003 Nov;29(11):1996-2003. doi: 10.1007/s00134-003-2016-4. Epub 2003 Oct 7. Intensive Care Med. 2003. PMID: 14530859 Clinical Trial.
-
Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).Vascul Pharmacol. 2007 Jun;46(6):449-55. doi: 10.1016/j.vph.2007.01.008. Epub 2007 Feb 12. Vascul Pharmacol. 2007. PMID: 17368113 Clinical Trial.
-
Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension.J Cardiothorac Vasc Anesth. 2004 Dec;18(6):775-6. doi: 10.1053/j.jvca.2004.08.021. J Cardiothorac Vasc Anesth. 2004. PMID: 15650993 No abstract available.
-
Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.Clin Perinatol. 2012 Mar;39(1):149-64. doi: 10.1016/j.clp.2011.12.006. Clin Perinatol. 2012. PMID: 22341543 Free PMC article. Review.
-
Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.Curr Opin Pharmacol. 2005 Jun;5(3):245-50. doi: 10.1016/j.coph.2004.12.008. Curr Opin Pharmacol. 2005. PMID: 15907910 Review.
Cited by
-
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.J Vet Intern Med. 2020 Mar;34(2):549-573. doi: 10.1111/jvim.15725. Epub 2020 Feb 17. J Vet Intern Med. 2020. PMID: 32065428 Free PMC article.
-
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.Curr Heart Fail Rep. 2004 Dec;1(4):183-9. doi: 10.1007/s11897-004-0007-6. Curr Heart Fail Rep. 2004. PMID: 16036043 Review.
-
Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism.Intensive Care Med. 2006 Mar;32(3):452-4. doi: 10.1007/s00134-005-0058-5. Epub 2006 Feb 1. Intensive Care Med. 2006. PMID: 16450094
-
Role of Phosphodiesterase-5 Inhibitors in Acute Right Ventricular Failure Due to Pulmonary Embolism.Am J Case Rep. 2019 Aug 4;20:1144-1147. doi: 10.12659/AJCR.915832. Am J Case Rep. 2019. PMID: 31377751 Free PMC article.
-
Pulmonary vasodilation in acute pulmonary embolism - a systematic review.Pulm Circ. 2020 Mar 4;10(1):2045894019899775. doi: 10.1177/2045894019899775. eCollection 2020 Jan-Mar. Pulm Circ. 2020. PMID: 32180938 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials